Advertisement

Topics

Spark shares tank after haemophilia gene therapy safety signal

05:34 EDT 8 Aug 2018 | pharmaphorum

There are serious doubts about Spark Therapeutics’ haemophilia A gene therapy after two out of seven patients on a high dose in an early-stage trial suffered a serious immune response. The news of a safety concern with the treatment sent the compa...

Original Article: Spark shares tank after haemophilia gene therapy safety signal

NEXT ARTICLE

More From BioPortfolio on "Spark shares tank after haemophilia gene therapy safety signal"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...